Alpha Teknova (NASDAQ:TKNO) Receives Overweight Rating from Stephens

Alpha Teknova (NASDAQ:TKNO)‘s stock had its “overweight” rating restated by investment analysts at Stephens in a note issued to investors on Wednesday, Benzinga reports. They currently have a $5.00 price target on the stock. Stephens’ price objective suggests a potential upside of 303.23% from the company’s previous close.

Separately, BTIG Research lowered Alpha Teknova from a “buy” rating to a “neutral” rating in a research note on Tuesday, March 12th.

Alpha Teknova Stock Performance

NASDAQ:TKNO opened at $1.24 on Wednesday. The firm’s 50-day moving average is $1.63 and its 200-day moving average is $2.46. The company has a market cap of $50.62 million, a price-to-earnings ratio of -1.18 and a beta of 0.33. The company has a debt-to-equity ratio of 0.16, a quick ratio of 3.92 and a current ratio of 5.52. Alpha Teknova has a 52-week low of $1.16 and a 52-week high of $4.27.

Alpha Teknova (NASDAQ:TKNO) last issued its quarterly earnings results on Monday, May 13th. The company reported ($0.20) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.24) by $0.04. The firm had revenue of $9.29 million for the quarter, compared to analyst estimates of $7.80 million. Alpha Teknova had a negative return on equity of 38.24% and a negative net margin of 97.85%. During the same period in the previous year, the company posted ($0.31) earnings per share. Equities research analysts anticipate that Alpha Teknova will post -0.65 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. FourWorld Capital Management LLC acquired a new stake in Alpha Teknova during the first quarter valued at approximately $135,000. Redmile Group LLC lifted its position in shares of Alpha Teknova by 6.5% during the 1st quarter. Redmile Group LLC now owns 171,453 shares of the company’s stock worth $434,000 after buying an additional 10,448 shares during the period. State Board of Administration of Florida Retirement System acquired a new stake in Alpha Teknova in the 1st quarter valued at $35,000. Fielder Capital Group LLC bought a new stake in Alpha Teknova in the fourth quarter valued at $156,000. Finally, Conestoga Capital Advisors LLC raised its stake in Alpha Teknova by 4.1% during the fourth quarter. Conestoga Capital Advisors LLC now owns 247,529 shares of the company’s stock worth $923,000 after acquiring an additional 9,800 shares in the last quarter. Institutional investors and hedge funds own 13.81% of the company’s stock.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.